| pubmed-article:11153146 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11153146 | lifeskim:mentions | umls-concept:C0006142 | lld:lifeskim |
| pubmed-article:11153146 | lifeskim:mentions | umls-concept:C1516213 | lld:lifeskim |
| pubmed-article:11153146 | lifeskim:mentions | umls-concept:C0035820 | lld:lifeskim |
| pubmed-article:11153146 | lifeskim:mentions | umls-concept:C0013216 | lld:lifeskim |
| pubmed-article:11153146 | lifeskim:mentions | umls-concept:C0376515 | lld:lifeskim |
| pubmed-article:11153146 | lifeskim:mentions | umls-concept:C0079419 | lld:lifeskim |
| pubmed-article:11153146 | lifeskim:mentions | umls-concept:C0332293 | lld:lifeskim |
| pubmed-article:11153146 | lifeskim:mentions | umls-concept:C1522673 | lld:lifeskim |
| pubmed-article:11153146 | pubmed:issue | 12 | lld:pubmed |
| pubmed-article:11153146 | pubmed:dateCreated | 2001-1-10 | lld:pubmed |
| pubmed-article:11153146 | pubmed:abstractText | Adjuvant therapy has become an integral component of the managment of primary high-risk breast cancer patients. However, a considerable fraction of women receive no benefit from this treatment. This study investigates whether a number of biopathological factors can influence the outcome of patients submitted to adjuvant chemotherapy involving the use of high-dose epirubicin and cyclophosphamide. | lld:pubmed |
| pubmed-article:11153146 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11153146 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11153146 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11153146 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11153146 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11153146 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11153146 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11153146 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11153146 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11153146 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11153146 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11153146 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:11153146 | pubmed:issn | 0171-5216 | lld:pubmed |
| pubmed-article:11153146 | pubmed:author | pubmed-author:MottoleseMM | lld:pubmed |
| pubmed-article:11153146 | pubmed:author | pubmed-author:BottiCC | lld:pubmed |
| pubmed-article:11153146 | pubmed:author | pubmed-author:Di FilippoFF | lld:pubmed |
| pubmed-article:11153146 | pubmed:author | pubmed-author:BenevoloMM | lld:pubmed |
| pubmed-article:11153146 | pubmed:author | pubmed-author:VickRR | lld:pubmed |
| pubmed-article:11153146 | pubmed:author | pubmed-author:PapaldoPP | lld:pubmed |
| pubmed-article:11153146 | pubmed:author | pubmed-author:NisticòCC | lld:pubmed |
| pubmed-article:11153146 | pubmed:author | pubmed-author:VasselliSS | lld:pubmed |
| pubmed-article:11153146 | pubmed:author | pubmed-author:Del MonteGG | lld:pubmed |
| pubmed-article:11153146 | pubmed:author | pubmed-author:BuglioniSS | lld:pubmed |
| pubmed-article:11153146 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11153146 | pubmed:volume | 126 | lld:pubmed |
| pubmed-article:11153146 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11153146 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11153146 | pubmed:pagination | 722-9 | lld:pubmed |
| pubmed-article:11153146 | pubmed:dateRevised | 2009-11-19 | lld:pubmed |
| pubmed-article:11153146 | pubmed:meshHeading | pubmed-meshheading:11153146... | lld:pubmed |
| pubmed-article:11153146 | pubmed:meshHeading | pubmed-meshheading:11153146... | lld:pubmed |
| pubmed-article:11153146 | pubmed:meshHeading | pubmed-meshheading:11153146... | lld:pubmed |
| pubmed-article:11153146 | pubmed:meshHeading | pubmed-meshheading:11153146... | lld:pubmed |
| pubmed-article:11153146 | pubmed:meshHeading | pubmed-meshheading:11153146... | lld:pubmed |
| pubmed-article:11153146 | pubmed:meshHeading | pubmed-meshheading:11153146... | lld:pubmed |
| pubmed-article:11153146 | pubmed:meshHeading | pubmed-meshheading:11153146... | lld:pubmed |
| pubmed-article:11153146 | pubmed:meshHeading | pubmed-meshheading:11153146... | lld:pubmed |
| pubmed-article:11153146 | pubmed:meshHeading | pubmed-meshheading:11153146... | lld:pubmed |
| pubmed-article:11153146 | pubmed:meshHeading | pubmed-meshheading:11153146... | lld:pubmed |
| pubmed-article:11153146 | pubmed:meshHeading | pubmed-meshheading:11153146... | lld:pubmed |
| pubmed-article:11153146 | pubmed:meshHeading | pubmed-meshheading:11153146... | lld:pubmed |
| pubmed-article:11153146 | pubmed:meshHeading | pubmed-meshheading:11153146... | lld:pubmed |
| pubmed-article:11153146 | pubmed:meshHeading | pubmed-meshheading:11153146... | lld:pubmed |
| pubmed-article:11153146 | pubmed:meshHeading | pubmed-meshheading:11153146... | lld:pubmed |
| pubmed-article:11153146 | pubmed:meshHeading | pubmed-meshheading:11153146... | lld:pubmed |
| pubmed-article:11153146 | pubmed:meshHeading | pubmed-meshheading:11153146... | lld:pubmed |
| pubmed-article:11153146 | pubmed:meshHeading | pubmed-meshheading:11153146... | lld:pubmed |
| pubmed-article:11153146 | pubmed:meshHeading | pubmed-meshheading:11153146... | lld:pubmed |
| pubmed-article:11153146 | pubmed:meshHeading | pubmed-meshheading:11153146... | lld:pubmed |
| pubmed-article:11153146 | pubmed:meshHeading | pubmed-meshheading:11153146... | lld:pubmed |
| pubmed-article:11153146 | pubmed:meshHeading | pubmed-meshheading:11153146... | lld:pubmed |
| pubmed-article:11153146 | pubmed:meshHeading | pubmed-meshheading:11153146... | lld:pubmed |
| pubmed-article:11153146 | pubmed:year | 2000 | lld:pubmed |
| pubmed-article:11153146 | pubmed:articleTitle | Role of P53 and BCL-2 in high-risk breast cancer patients treated with adjuvant anthracycline-based chemotherapy. | lld:pubmed |
| pubmed-article:11153146 | pubmed:affiliation | Pathology Department, Regina Elena Cancer Institute, Rome, Italy. | lld:pubmed |
| pubmed-article:11153146 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11153146 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11153146 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11153146 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11153146 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11153146 | lld:pubmed |
